Wolverine Trading, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	BUY	$9.17 - $19.29 $195,321 - $410,877	21,300 New	21,300 $235,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $277,167 - $447,190	22,700 Added 174.62%	35,700 $586,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $64,011 - $111,663	-5,700 Reduced 30.48%	13,000 $178,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $179,158 - $238,386	-13,400 Reduced 41.74%	18,700 $304,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $139,944 - $191,394	-9,800 Reduced 23.39%	32,100 $524,000
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $210,438 - $331,614	16,200 Added 63.04%	41,900 $636,000
Q2 2021 Aug 06, 2021	BUY	$15.46 - $24.5 $151,508 - $240,100	9,800 Added 61.64%	25,700 $542,000
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $357,604 - $698,375	-18,500 Reduced 53.78%	15,900 $360,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $117,504 - $203,856	4,800 Added 16.22%	34,400 $880,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $97,725 - $133,600	-2,500 Reduced 7.79%	29,600 $1.24 Million
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $32,690 - $64,428	-700 Reduced 2.13%	32,100 $1.5 Million
Q1 2020 May 11, 2020	SELL	$48.35 - $118.68 $2.69 Million - $6.6 Million	-55,600 Reduced 62.9%	32,800 $2.13 Million
Q4 2019 Feb 12, 2020	BUY	$57.36 - $124.1 $1.64 Million - $3.55 Million	28,600 Added 47.83%	88,400 $10.9 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $962,516 - $1.32 Million	16,400 Added 37.79%	59,800 $3.83 Million
Q2 2019 Aug 20, 2019	SELL	$77.77 - $120.68 $2.07 Million - $3.21 Million	-26,600 Reduced 38.0%	43,400 $3.45 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $1.58 Million - $2.08 Million	-17,200 Reduced 19.72%	70,000 $7.83 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $875,058 - $1.29 Million	-10,200 Reduced 10.47%	87,200 $8.2 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $5.28 Million - $7.61 Million	59,700 Added 158.36%	97,400 $12.3 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $1.99 Million - $2.54 Million	37,700 New	37,700 $2.32 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account